Exelixis Inc. buy Royal Bank of Canada
Start price
14.05.25
/
50%
€39.53
Target price
14.05.26
€35.75
Performance (%)
-10.93%
Price
15.12.25
€35.21
Summary
This prediction is currently active. The price of Exelixis Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.93%. This prediction currently runs until 14.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Exelixis Inc. | -2.815% | -2.815% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $40.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat